• PRODUCT AVAILABILITY: Did you know you can view a product's availability right on the product page? Simply enter the quantity you want to purchase and the current availability will appear below the item.

  • Product is restricted and can only be purchased by customers with a web profile linked to a Thomas Business Account - Click here to login or create your web profile. If you do not have a Thomas Business Account, please Contact Us and someone will respond with details on how to apply for a business account with us.

G-Biosciences

E-64 (N-(N-(L-3 Trans-carboxirane-2-carbonyl)-L-leucyl)-agmatine)

Not yet rated

NOTE: Due to special handling or shipping requirements, these products will have additional fees added during checkout. Click HERE for a description of what fees might be charged.

E-64

L-trans-epoxysuccinyl-leucylamide-(4-guanido)-butane or N-[N-(L-trans-carboxyoxiran-2-carbonyl)-L-leucyl]-agmatine

Features

  • CAS Number: 66701-25-5
  • Molecular Formula : C₁₅H₂₇Nâ‚…Oâ‚…
  • Molecular Weight: 357.4 g/mol
  • Synonym: Proteinase Inhibitor E-64
  • Solubility: Soluble in DMSO (25mg/ml)& aqueous buffers (20mg/ml)
  • Specificity: Irreversible inhibitor of cysteine proteases; does not inhibit serine proteases

Please Enter Your Order Info

Filter by:

  • Clear Filters
Product Detail
Thomas No.
C753X11
Mfr. No.
786-049
Description
E-64 (N-(N-(L-3 Trans-carboxirane-2-carbonyl)-L-leucyl)-agmatine), 5mg
CAS Number
66701-25-5
Packaging Size
5 mg
list price/quantitytotal
$0.00
Thomas No.
C752L48
Mfr. No.
786-985
Description
E-64 (N-(N-(L-3 Trans-carboxirane-2-carbonyl)-L-leucyl)-agmatine), 25mg
CAS Number
66701-25-5
Packaging Size
25 mg
list price/quantitytotal
$0.00
$0.00 (0 Items)
Product is restricted and can only be purchased by customers with a web profile linked to a Thomas Business Account - Click here to login or create your web profile. If you do not have a Thomas Business Account, please Contact Us and someone will respond with details on how to apply for a business account with us.

Write A Review